Euro
USD
British Pound
NULL
Product Description
PLX5622 is an inhibitor of colony-stimulating factor 1 receptor (CSF1R) tyrosine kinase with a Ki of 5.9 nM. It causes sustained and specific elimination of microglia. As a result of microglial depletion, plaques fail to form in the parenchymal space in the 5xFAD mouse model of Alzheimer’s disease (AD). Inhibition of the CSF1R at lower doses in 3xTg-AD mice prevents microglial association with plaques and improves cognition.
PLX5622 is an inhibitor of colony-stimulating factor 1 receptor (CSF1R) tyrosine kinase with a Ki of 5.9 nM. It causes sustained and specific elimination of microglia. As a result of microglial depletion, plaques fail to form in the parenchymal space in the 5xFAD mouse model of Alzheimer’s disease (AD). Inhibition of the CSF1R at lower doses in 3xTg-AD mice prevents microglial association with plaques and improves cognition.
Biovision | B2965 | PLX5622 (free base) DataSheet
Alternate Name/Synonyms: 6-fluoro-N-[(5-fluoro-2-methoxypyridin-3-yl)methyl]-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]pyridin-2-amine
Appearance: Solid
Formulation:
CAS Number: 1303420-67-8
Structure Available?: True
Peptide sequence:
Salt Form: false
Molecular Formula: C₂₁H₁₉F₂N₅O
Molecular Weight: 395.41
Cell-Permeable?: True
Purity: >98%
Solubilities: Soluble in DMSO in 0
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: An inhibitor of CSF1R
MDL Number:
PubChem CID: 52936034
SMILES: CC1=CC2=C(NC=C2CC3=C(N=C(C=C3)NCC4=C(N=CC(=C4)F)OC)F)N=C1
InChi: InChI=1S/C21H19F2N5O/c1-12-5-17-14(9-26-20(17)25-8-12)6-13-3-4-18(28-19(13)23)24-10-15-7-16(22)11-27-21(15)29-2/h3-5,7-9,11H,6,10H2,1-2H3,(H,24,28)(H,25,26)
InChi Key: NSMOZFXKTHCPTQ-UHFFFAOYSA-N
